who dr tb treatment guidelines?
The WHO recommends, albeit based on weak evidence, substitution of isoniazid with levofloxacin (Lfx) for the treatment of laboratory-confirmed Hr-TB (rifampicin-susceptible) and use of the drug regimen consisting of ERZ (ethambutol, rifampicin, pyrazinamide)-Lfx for a duration of six months without a split of intensive ...